|
Stoke Therapeutics Inc (NASDAQ: STOK) |
|
Stoke Therapeutics Inc
STOK's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Stoke Therapeutics Inc growth rates, revenue grew
by 707.35 % in the fourth quarter of 2024 from the same quarter a year ago.
Ranking at No. 2166
Major Pharmaceutical Preparations industry recorded
growth of revenues by 11.85 %
Stoke Therapeutics Inc net loss decreased from $-27 millions, to $-10 millions in fourth quarter of 2024,
• More on STOK's Growth
|
|
Stoke Therapeutics Inc realized a net loss in trailing twelve months.
Stoke Therapeutics Inc realized cash reduction of $ -1.17 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 14.25.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.21.
• More on STOK's Valuation
|
|
|
|
|
Stoke Therapeutics Inc realized net loss in trailing twelve months.
Stoke Therapeutics Inc realized cash outflow of $ -1.17per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 14.25.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.21.
Stoke Therapeutics Inc Price to Book Ratio is at 2.27 lower than Industry Avg. of 78.2. and higher than S&P 500 Avg. of 0.01
• More on STOK's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com